Towards optimization of ceftazidime dosing in obese ICU patients: the end of the 'one-size-fits-all' approach?

Obese ICU patients required significantly greater ceftazidime doses to achieve the target range. A tailored dosing regimen may be considered based on weight and GFR. Future prospective studies should be performed to confirm this individualized dosing approach.